Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia.

EBioMedicine(2019)

Cited 42|Views14
No score
Abstract
These data demonstrate durable functional benefit of hMUT mRNA and support development of this new class of therapy for a devastating, pediatric disorder. FUND: This work was funded by Moderna, Inc.
More
Translated text
Key words
Enzyme replacement,Liver targeted therapy,Methylmalonyl-CoA mutase,Organic acidemia,Systemic mRNA therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined